In the latest instalment of our Antitrust Review podcast, host Nick Levy is joined by colleagues from Cleary Gottlieb’s Brussels
Mergers & Acquisitions
Antitrust Review Episode 33: In Conversation with Brian McHugh
In the latest instalment of Cleary Gottlieb’s Antitrust Review podcast, host Nick Levy is joined by Brian McHugh, Chair of…
SAMR Streamlined Merger Notification Forms for Simple Cases
On September 14, 2024, China’s SAMR published streamlined notification and publicity forms for cases reviewed under its simplified merger review procedure (“Simple Cases”). The revised forms will take effect as of October 12, 2024.
Antitrust Review Episode 32:What To Expect Under the Labour Government
In this episode of Cleary Gottlieb’s Antitrust Review podcast, host Nick Levy is joined by a panel featuring Jackie Holland, Cleary partner and former Senior Director of the UK Office of Fair Trading; Ricardo Zimbrón, former Director of Mergers at the Competition & Markets Authority and currently a partner at Cleary; Alexander Baker, CEO, Fingleton; and John Gray, Partner, FGS Global, to discuss the implications of the new Labour Government for competition enforcement and practice in the UK. Their conversation covers an array of topics, including the new government’s growth agenda, the role of politics in antitrust enforcement, merger control, consumer protection, digital regulation, and much more.
Antitrust Review Episode 31: In Conversation With The Illumina/GRAIL Team
In the latest instalment of Cleary Gottlieb’s Antitrust Review podcast, host Nick Levy is joined by the team of lawyers…
Illumina/GRAIL: ECJ Rules European Commission Lacks Jurisdiction to Review Merger Falling Below EU and National Merger Thresholds
On September 3, 2024, in a landmark decision, the European Court of Justice – the EU’s highest court – ruled in favor of Illumina in its challenge to the EC’s unprecedented assertion of jurisdiction over a transaction that met no notification thresholds at either EU or Member State level.
Antitrust Review Episode 30: In Conversation with Martijn Snoep
In the latest instalment of Cleary Gottlieb’s Antitrust Review podcast, host Nick Levy is joined by Martijn Snoep, Chair of…
Antitrust Review Episode 28: In Conversation with George Cary
In our latest instalment, host Nick Levy speaks with George Cary, one of the leading U.S. antitrust lawyers of his…
No “killer acquisition” – FCO allows acquisition of Shockwave Medical by Johnson & Johnson
On 27 May 2024, the German Federal Cartel Office (“FCO”) gave the green light for Johnson & Johnson’s (“J&J”) 13.1 billion US dollar acquisition of Shockwave Medical (“Shockwave”).[1] The decision follows an in-depth investigation into the acquisition’s potential impact on competition and innovation, particularly in the burgeoning field of cardiovascular disease treatment, one of the fastest‑growing global med-tech markets.
Lufthansa/ITA: A New Era of Stringent Airline Merger Remedies
On July 3, 2024, the Commission conditionally approved Deutsche Lufthansa AG’s (“Lufthansa”) and the Italian Ministry of Economy and Finance’s (“MEF”) joint control of ITA Airways (“ITA”). [1] The approval is contingent upon full compliance with the commitments.